Concepedia

Author

Gertraud Stocker

Heidelberg UniversityORCID

Also Known As

G Stocker, G. Stocker, Gertraud Stocker

48

Publications

342

Citations

10

H-Index

14

Concepts

All Affiliations

Heidelberg UniversityUniversity Hospital LeipzigUniversity Hospital HeidelbergCharité - Universitätsmedizin BerlinUniversity Medical Center Hamburg-Eppendorf
GS

About

Gertraud Stocker is an author at Heidelberg University specializing in medicine, oncology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

107

2

Pathology

2

2

83

3

Gastroenterology

1

1

24

4

Immunology

1

1

23

5

Pharmacology

1

1

60

Gertraud Stocker

×

9

Publications

263

Citations

9

H-Index

YearCitations

Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: A randomised phase II trial of the Arbeitsgemeinschaft Internistische Onkologie

Sylvie Lorenzen, Jorge Riera Knorrenschild, Georg-Martin Haag,

European Journal of Cancer

2015

60

Prognostic role of body composition parameters in gastric/gastroesophageal junction cancer patients from the EXPAND trial

Ulrich Hacker, Dirk Hasenclever, Nicolas Linder,

Journal of Cachexia Sarcopenia and Muscle

2019

59

Adjuvant immunotherapy in patients with resected gastric and oesophagogastric junction cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1): European Organisation of Research and Treatment of Cancer (EORTC) 1707 VESTIGE study

Florian Lordick, M. Mauer, Gertraud Stocker,

Annals of Oncology

2024

29

Second-line therapy with nivolumab plus ipilimumab for older patients with oesophageal squamous cell cancer (RAMONA): a multicentre, open-label phase 2 trial

Matthias Ebert, Nadja M. Meindl‐Beinker, Tobias Gutting,

The Lancet Healthy Longevity

2022

28

Clinical consequences of chemotherapy dose reduction in obese patients with stage III colon cancer: A retrospective analysis from the PETACC 3 study

Gertraud Stocker, Ulrich Hacker, Frédéric Fiteni,

European Journal of Cancer

2018

24

CyclinD1 and interleukin-1 receptor antagonist polymorphisms are associated with prognosis in neoadjuvant-treated gastric carcinoma

Gertraud Stocker, Katja Ott, Nils Olav Henningsen,

European Journal of Cancer

2009

23

Randomized controlled trial of S-1 maintenance therapy in metastatic esophagogastric cancer – the multinational MATEO study

Georg-Martin Haag, Gertraud Stocker, Julia Quidde,

BMC Cancer

2017

15

Ramucirumab, Avelumab, and Paclitaxel as Second-Line Treatment in Esophagogastric Adenocarcinoma

Peter Thuss‐Patience, Anica Högner, Eray Goekkurt,

JAMA Network Open

2024

13

Guideline adherence and implementation of tumor board therapy recommendations for patients with gastrointestinal cancer

Alina Krause, Gertraud Stocker, Ines Gockel,

Journal of Cancer Research and Clinical Oncology

2022

12

Page 1